Outset Medical counsel tax-related share sale filed
Outset Medical, Inc. General Counsel John L. Brottem reported an open-market sale of 2,638 shares of Common Stock at $3.70 per share.
Rhea-AI Filing Summary
Outset Medical, Inc. General Counsel John L. Brottem reported an open-market sale of 2,638 shares of Common Stock at $3.70 per share. According to the footnotes, this was a required "sell to cover" transaction to satisfy tax withholding obligations tied to the vesting of 5,033 RSU-based shares and is not a discretionary trade. After this tax-related sale, Brottem directly holds 30,277 shares of Common Stock. A separate footnote notes a correction to a previously reported 2,842-share tax-related sale, revising it to 2,862 shares due to an administrative error.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,638 | $3.70 | $10K |
Footnotes (2)
- F1. Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,033 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- F2. This balance reflects a correction to the number of shares of Common Stock sold by the reporting person to satisfy tax withholding obligations as previously reported on a Form 4 filed on February 19, 2026. Due to an administrative error, the prior Form 4 reported the sale of 2,842 shares instead of the correct number, 2,862 shares.
Key Figures
Key Terms
RSUs financial
sell to cover financial
tax withholding obligations financial
Form 4 regulatory
administrative error other
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Outset Medical (OM) report for John L. Brottem?
Was the Outset Medical (OM) insider sale by John L. Brottem a discretionary trade?
Did Outset Medical (OM) correct any prior Form 4 data for John L. Brottem?
What is a "sell to cover" transaction in the context of Outset Medical (OM) RSUs?
AI-generated analysis. How Rhea-AI works. Not financial advice.